Ludwig Lausanne study shows how tumors turn immune cells into enablers of their growth

OCTOBER 25, 2021, NEW YORK – A Ludwig Cancer Research study has identified a means by which cancer cells engineer the conversion of immune cells known

Related Keywords

Sweden ,United States ,Abu Dhabi ,Abuz Aby ,United Arab Emirates ,Switzerland ,France ,French ,American ,Swedish ,Swiss , ,Us National Institutes Of Health ,Cancer Research Institute ,A Ludwig Cancer Research ,Cleveland Digestive Diseases Research Core Center ,Swedish Cancer Society ,Swiss National Science Foundation ,University Of Lausanne ,American Cancer Society ,York University Abu Dhabi Research Enhancement Fund ,Swiss Institute For Experimental Cancer Research ,Ludwig Cancer Research ,French National Research Agency ,Swedish Research Council ,European Research Council ,Ludwig Institute For Cancer Research ,Swiss Cancer League ,Ludwig Lausanne ,Giusy Di Conza ,Nature Immunology ,Ludwig Institute ,Cancer Research ,Swiss Institute ,Experimental Cancer Research ,Velosano Pilot Award ,Swiss Cancer ,